IFOSFAMIDE vs IMDEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IFOSFAMIDE vs IMDEVIMAB: Safety Overview
| Metric | IFOSFAMIDE | IMDEVIMAB |
|---|---|---|
| Total FAERS Reports | 17,004 | 432 |
| Deaths Reported | 3,365 | 24 |
| Death Rate | 19.8% | 5.6% |
| Hospitalizations | 5,230 | 202 |
| Average Patient Age | 36.2 yrs | 56.2 yrs |
| % Female Patients | 41.7% | 52.7% |
| FDA Approval Date | Apr 4, 2007 | N/A |
| Manufacturer | Baxter Healthcare Corporation | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | Prescription | N/A |